Galapagos NV
GLPG
#4935
Rank
NZ$3.18 B
Marketcap
NZ$47.49
Share price
0.53%
Change (1 day)
4.76%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -NZ$0.92 Billion

According to Galapagos NV's latest financial reports the company's current earnings are NZ$0.32 Billion. In 2024 the company made an earning of -NZ$9.8 Million, an increase over its 2023 earnings that were of -NZ$56.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.92 Billion9225.03%
2024 -NZ$9.8 Million-82.77%
2023 -NZ$56.88 Million-85.59%
2022 -NZ$0.4 Billion60.71%
2021 -NZ$0.25 Billion-60.08%
2020 -NZ$0.62 Billion-331.44%
2019 NZ$0.26 B-523.76%
2018 -NZ$62.75 Million-72.34%
2017 -NZ$0.23 Billion-329.59%
2016 NZ$98.81 M-144.3%
2015 -NZ$0.23 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$56.89 B-6,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$14.35 B-1,690.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$11.18 B-1,339.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.05 B-1,546.16%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$38.02 B-4,311.72%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$23.92 B-2,749.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$16.78 B-1,958.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-NZ$90.68 Million-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.64 B-504.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel